List of Excipients in API cyclosporine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing cyclosporine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Allergan Inc | RESTASIS MULTIDOSE | cyclosporine | 0023-5301 | CARBOMER COPOLYMER TYPE A | |
| Allergan Inc | RESTASIS MULTIDOSE | cyclosporine | 0023-5301 | CASTOR OIL | |
| Allergan Inc | RESTASIS MULTIDOSE | cyclosporine | 0023-5301 | GLYCERIN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing cyclosporine
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| AbbVie Inc | cyclosporine | 0074-0541 | ALCOHOL |
| AbbVie Inc | cyclosporine | 0074-0541 | FD&C BLUE NO. 2 |
| AbbVie Inc | cyclosporine | 0074-0541 | GELATIN |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for cyclosporine
Excipient focus: .ALPHA.-TOCOPHEROL
cyclosporine drug variants containing .ALPHA.-TOCOPHEROL
| Company | Ingredient | NDC |
|---|---|---|
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | cyclosporine | 23155-837 |
| Mayne Pharma Inc | cyclosporine | 51862-458 |
| Strides Pharma Science Limited | cyclosporine | 64380-127 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing .ALPHA.-TOCOPHEROL
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: .ALPHA.-TOCOPHEROL, DL-
cyclosporine drug variants containing .ALPHA.-TOCOPHEROL, DL-
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | cyclosporine | 0093-5740 |
| Teva Pharmaceuticals USA Inc | cyclosporine | 0093-9018 |
| Physicians Total Care Inc | cyclosporine | 54868-6232 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing .ALPHA.-TOCOPHEROL, DL-
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: 1,1,1,2,2,3,3,4,4-NONAFLUORONONANE
cyclosporine drug variants containing 1,1,1,2,2,3,3,4,4-NONAFLUORONONANE
| Company | Ingredient | NDC |
|---|---|---|
| Harrow Eye LLC | cyclosporine ophthalmic solution | 82667-900 |
| Novaliq GmbH | cyclosporine ophthalmic solution | 83339-002 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing 1,1,1,2,2,3,3,4,4-NONAFLUORONONANE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALCOHOL
cyclosporine drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | cyclosporine | 0074-0541 |
| Novartis Pharmaceuticals Corporation | cyclosporine | 0078-0240 |
| Teva Pharmaceuticals USA Inc | cyclosporine | 0093-5740 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-7269 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALUMINUM OXIDE
cyclosporine drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | cyclosporine | 54868-6232 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
cyclosporine drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | cyclosporine | 23155-837 |
| Strides Pharma Science Limited | cyclosporine | 64380-127 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
cyclosporine drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | cyclosporine | 54868-5522 |
| Apotex Corp | cyclosporine | 60505-0133 |
| American Health Packaging | cyclosporine | 68084-879 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: CAPRYLOCAPROYL POLYOXYLGLYCERIDES 8
cyclosporine drug variants containing CAPRYLOCAPROYL POLYOXYLGLYCERIDES 8
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma Inc | cyclosporine | 51862-458 |
| Dr Reddy's Laboratories Inc | cyclosporine | 75907-047 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing CAPRYLOCAPROYL POLYOXYLGLYCERIDES 8
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOMER COPOLYMER TYPE A
cyclosporine drug variants containing CARBOMER COPOLYMER TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| Mylan Pharmaceuticals Inc | cyclosporine | 0378-8760 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing CARBOMER COPOLYMER TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | cyclosporine | 0074-0541 |
| AbbVie Inc | cyclosporine | 0074-7269 |
| Novartis Pharmaceuticals Corporation | cyclosporine | 0078-0240 |
| >Company | >Ingredient | >NDC |
Excipient focus: CASTOR OIL
cyclosporine drug variants containing CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| Novartis Pharmaceuticals Corporation | cyclosporine | 0078-0240 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | cyclosporine | 0074-0541 |
| AbbVie Inc | cyclosporine | 0074-7269 |
| Novartis Pharmaceuticals Corporation | cyclosporine | 0078-0246 |
| >Company | >Ingredient | >NDC |
Excipient focus: CETALKONIUM CHLORIDE
cyclosporine drug variants containing CETALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Santen Incorporated | cyclosporine | 65086-001 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing CETALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: COCHINEAL
cyclosporine drug variants containing COCHINEAL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | cyclosporine | 0078-0246 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing COCHINEAL
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: CORN GLYCERIDES
cyclosporine drug variants containing CORN GLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | cyclosporine | 23155-837 |
| Strides Pharma Science Limited | cyclosporine | 64380-127 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing CORN GLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: CORN OIL
cyclosporine drug variants containing CORN OIL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | cyclosporine | 0078-0240 |
| Novartis Pharmaceuticals Corporation | cyclosporine | 0078-0246 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing CORN OIL
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
cyclosporine drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | cyclosporine | 54868-5522 |
| Apotex Corp | cyclosporine | 60505-0133 |
| American Health Packaging | cyclosporine | 68084-879 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
cyclosporine drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | cyclosporine | 54868-5522 |
| Apotex Corp | cyclosporine | 60505-0133 |
| American Health Packaging | cyclosporine | 68084-879 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
cyclosporine drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | cyclosporine | 0074-0541 |
| Physicians Total Care Inc | cyclosporine | 54868-5522 |
| Physicians Total Care Inc | cyclosporine | 54868-6232 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-7269 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
cyclosporine drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | cyclosporine | 54868-5522 |
| Apotex Corp | cyclosporine | 60505-0133 |
| American Health Packaging | cyclosporine | 68084-879 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
cyclosporine drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | cyclosporine | 0078-0240 |
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | cyclosporine | 23155-837 |
| Mayne Pharma Inc | cyclosporine | 51862-458 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
cyclosporine drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | cyclosporine | 0093-5740 |
| Teva Pharmaceuticals USA Inc | cyclosporine | 0093-9018 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
cyclosporine drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | cyclosporine | 0078-0246 |
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | cyclosporine | 23155-837 |
| Physicians Total Care Inc | cyclosporine | 54868-5522 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
cyclosporine drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | cyclosporine | 0074-0541 |
| Novartis Pharmaceuticals Corporation | cyclosporine | 0078-0240 |
| Novartis Pharmaceuticals Corporation | cyclosporine | 0078-0246 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-7269 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN HYDROLYSATE
cyclosporine drug variants containing GELATIN HYDROLYSATE
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | cyclosporine | 60505-4630 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing GELATIN HYDROLYSATE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
cyclosporine drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| Novartis Pharmaceuticals Corporation | cyclosporine | 0078-0240 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | cyclosporine | 0074-0541 |
| AbbVie Inc | cyclosporine | 0074-7269 |
| Teva Pharmaceuticals USA Inc | cyclosporine | 0172-7313 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOCAPRYLATE
cyclosporine drug variants containing GLYCERYL MONOCAPRYLATE
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma Inc | cyclosporine | 51862-458 |
| Dr Reddy's Laboratories Inc | cyclosporine | 75907-047 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing GLYCERYL MONOCAPRYLATE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOLINOLEATE
cyclosporine drug variants containing GLYCERYL MONOLINOLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | cyclosporine | 0093-9018 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing GLYCERYL MONOLINOLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCINE
cyclosporine drug variants containing GLYCINE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | cyclosporine | 0093-5740 |
| Teva Pharmaceuticals USA Inc | cyclosporine | 0093-9018 |
| Physicians Total Care Inc | cyclosporine | 54868-6232 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing GLYCINE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
cyclosporine drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | cyclosporine | 47335-506 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
cyclosporine drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | cyclosporine | 60505-4630 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
cyclosporine drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma Inc | cyclosporine | 51862-458 |
| Santen Incorporated | cyclosporine | 65086-001 |
| Dr Reddy's Laboratories Inc | cyclosporine | 75907-047 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYL ALCOHOL
cyclosporine drug variants containing METHYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | cyclosporine | 54868-5522 |
| Apotex Corp | cyclosporine | 60505-0133 |
| American Health Packaging | cyclosporine | 68084-879 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing METHYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: NONCRYSTALLIZING SORBITOL SOLUTION
cyclosporine drug variants containing NONCRYSTALLIZING SORBITOL SOLUTION
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | cyclosporine | 0093-9018 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing NONCRYSTALLIZING SORBITOL SOLUTION
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: OCTOXYNOL-40
cyclosporine drug variants containing OCTOXYNOL-40
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | cyclosporine | 47335-506 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing OCTOXYNOL-40
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: OLIVE OIL
cyclosporine drug variants containing OLIVE OIL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | cyclosporine | 0078-0240 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing OLIVE OIL
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 188
cyclosporine drug variants containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| Santen Incorporated | cyclosporine | 65086-001 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
cyclosporine drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-7269 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
cyclosporine drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | cyclosporine | 23155-837 |
| Apotex Corp | cyclosporine | 60505-4630 |
| Strides Pharma Science Limited | cyclosporine | 64380-127 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYGLYCERYL-10 OLEATE
cyclosporine drug variants containing POLYGLYCERYL-10 OLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | cyclosporine | 0093-5740 |
| Teva Pharmaceuticals USA Inc | cyclosporine | 0172-7313 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing POLYGLYCERYL-10 OLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYGLYCERYL-3 OLEATE
cyclosporine drug variants containing POLYGLYCERYL-3 OLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | cyclosporine | 0093-5740 |
| Teva Pharmaceuticals USA Inc | cyclosporine | 0172-7313 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing POLYGLYCERYL-3 OLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYOXYL 35 CASTOR OIL
cyclosporine drug variants containing POLYOXYL 35 CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | cyclosporine | 0074-0541 |
| Padagis US LLC | cyclosporine | 0574-0866 |
| Mayne Pharma Inc | cyclosporine | 51862-458 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing POLYOXYL 35 CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-7269 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYOXYL 40 HYDROGENATED CASTOR OIL
cyclosporine drug variants containing POLYOXYL 40 HYDROGENATED CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | cyclosporine | 0074-7269 |
| Novartis Pharmaceuticals Corporation | cyclosporine | 0078-0246 |
| Teva Pharmaceuticals USA Inc | cyclosporine | 0093-5740 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing POLYOXYL 40 HYDROGENATED CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
cyclosporine drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | cyclosporine | 0074-7269 |
| Novartis Pharmaceuticals Corporation | cyclosporine | 0078-0240 |
| Novartis Pharmaceuticals Corporation | cyclosporine | 0078-0246 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ACETATE PHTHALATE
cyclosporine drug variants containing POLYVINYL ACETATE PHTHALATE
| Company | Ingredient | NDC |
|---|---|---|
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | cyclosporine | 23155-837 |
| Strides Pharma Science Limited | cyclosporine | 64380-127 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing POLYVINYL ACETATE PHTHALATE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K90
cyclosporine drug variants containing POVIDONE K90
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | cyclosporine | 47335-506 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing POVIDONE K90
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
cyclosporine drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | cyclosporine | 0074-0541 |
| AbbVie Inc | cyclosporine | 0074-7269 |
| Novartis Pharmaceuticals Corporation | cyclosporine | 0078-0246 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| Novartis Pharmaceuticals Corporation | cyclosporine | 0078-0240 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL MONOLAURATE
cyclosporine drug variants containing PROPYLENE GLYCOL MONOLAURATE
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | cyclosporine | 60505-4630 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing PROPYLENE GLYCOL MONOLAURATE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
cyclosporine drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma Inc | cyclosporine | 51862-458 |
| Physicians Total Care Inc | cyclosporine | 54868-5522 |
| American Health Packaging | cyclosporine | 68084-879 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
cyclosporine drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | cyclosporine | 47335-506 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
cyclosporine drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| Mylan Pharmaceuticals Inc | cyclosporine | 0378-8760 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | cyclosporine | 0074-0541 |
| AbbVie Inc | cyclosporine | 0074-7269 |
| Novartis Pharmaceuticals Corporation | cyclosporine | 0078-0240 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
cyclosporine drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | cyclosporine | 54868-5522 |
| Apotex Corp | cyclosporine | 60505-0133 |
| American Health Packaging | cyclosporine | 68084-879 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
cyclosporine drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | cyclosporine | 47335-506 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE
cyclosporine drug variants containing SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | cyclosporine | 47335-506 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITAN MONOOLEATE
cyclosporine drug variants containing SORBITAN MONOOLEATE
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | cyclosporine | 0074-0541 |
| AbbVie Inc | cyclosporine | 0074-7269 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing SORBITAN MONOOLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| Novartis Pharmaceuticals Corporation | cyclosporine | 0078-0240 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
cyclosporine drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | cyclosporine | 0078-0240 |
| Teva Pharmaceuticals USA Inc | cyclosporine | 0093-5740 |
| Mayne Pharma Inc | cyclosporine | 51862-458 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
cyclosporine drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | cyclosporine | 54868-5522 |
| Apotex Corp | cyclosporine | 60505-0133 |
| American Health Packaging | cyclosporine | 68084-879 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
cyclosporine drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | cyclosporine | 0074-0541 |
| Novartis Pharmaceuticals Corporation | cyclosporine | 0078-0240 |
| Novartis Pharmaceuticals Corporation | cyclosporine | 0078-0246 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-7269 |
| >Company | >Ingredient | >NDC |
Excipient focus: TOCOPHEROL
cyclosporine drug variants containing TOCOPHEROL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | cyclosporine | 0078-0246 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing TOCOPHEROL
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: TYLOXAPOL
cyclosporine drug variants containing TYLOXAPOL
| Company | Ingredient | NDC |
|---|---|---|
| Santen Incorporated | cyclosporine | 65086-001 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing TYLOXAPOL
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| AbbVie Inc | cyclosporine | 0074-0541 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
cyclosporine drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | cyclosporine | 0023-5301 |
| Allergan Inc | cyclosporine | 0023-9163 |
| Mylan Pharmaceuticals Inc | cyclosporine | 0378-8760 |
| >Company | >Ingredient | >NDC |
cyclosporine drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | cyclosporine | 0074-0541 |
| AbbVie Inc | cyclosporine | 0074-7269 |
| Novartis Pharmaceuticals Corporation | cyclosporine | 0078-0240 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
